We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$207M
AUM Growth
+$72.1M
Cap. Flow
+$59.3M
Cap. Flow %
28.65%
Top 10 Hldgs %
47.42%
Holding
159
New
12
Increased
64
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$6.79M
2
WPZ
Williams Partners L.P.
WPZ
+$5.53M
3
BPL
Buckeye Partners, L.P.
BPL
+$5M
4
ET icon
Energy Transfer Partners
ET
+$3.75M
5
EPD icon
Enterprise Products Partners
EPD
+$3.26M

Top Sells

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$4.42M
2
MDVN
MEDIVATION, INC.
MDVN
+$546K
3
RLYP
RELYPSA INC COM
RLYP
+$521K
4
TRGP icon
Targa Resources
TRGP
+$430K
5
USO icon
United States Oil Fund
USO
+$16K

Sector Composition

Rank Sector Weight
1 Energy 63.86%
2 Healthcare 21.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGEN
76
Agenus
AGEN
$249M
$454K 0.22%
3,220
– –
XNCR icon
77
Xencor
XNCR
$1.44B
$432K 0.21%
17,649
– –
BLUE
78
DELISTED
bluebird bio
BLUE
$418K 0.2%
476
– –
SAGE
79
DELISTED
Sage Therapeutics
SAGE
$404K 0.2%
8,774
– –
BLCM
80
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$404K 0.2%
2,030
– –
BPMC
81
DELISTED
Blueprint Medicines
BPMC
$387K 0.19%
13,046
– –
RDUS
82
DELISTED
Radius Health, Inc.
RDUS
$378K 0.18%
6,986
– –
SGYP
83
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$376K 0.18%
68,254
– –
BCRX icon
84
BioCryst Pharmaceuticals
BCRX
$2.37B
$374K 0.18%
84,907
– –
LUMO
85
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$367K 0.18%
2,718
– –
NERV icon
86
Minerva Neurosciences
NERV
$188M
$362K 0.18%
3,204
– –
INSM icon
87
Insmed
INSM
$23.2B
$356K 0.17%
24,536
– –
LJPC
88
DELISTED
La Jolla Pharmaceutical Company
LJPC
$340K 0.16%
14,291
– –
PRTA icon
89
Prothena Corp
PRTA
$458M
$330K 0.16%
5,509
– –
ADXS
90
DELISTED
Advaxis Inc
ADXS
$330K 0.16%
2,059
– –
BWP
91
DELISTED
Boardwalk Pipeline Partners
BWP
$324K 0.16%
+18,873
New +$318K
CEMP
92
DELISTED
Cempra, Inc.
CEMP
$321K 0.16%
13,284
– –
LXRX icon
93
Lexicon Pharmaceuticals
LXRX
$1.02B
$319K 0.15%
17,649
– –
ARWR icon
94
Arrowhead Research
ARWR
$12.1B
$318K 0.15%
43,272
– –
ONCE
95
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$317K 0.15%
5,281
– –
SRNE
96
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$313K 0.15%
40,438
– –
KYNB
97
Kyntra Bio
KYNB
$28.5M
$308K 0.15%
595
– –
FPRX
98
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$306K 0.15%
5,837
– –
FOLD
99
DELISTED
Amicus Therapeutics
FOLD
$301K 0.15%
40,705
– –
KPTI icon
100
Karyopharm Therapeutics
KPTI
$168M
$298K 0.14%
2,041
– –
2 3
4
5 6

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, Virtus ETF Advisers held 159 positions worth $207M, up 53% from $135M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Virtus ETF Advisers deployed $59.3M of net new capital in Q3 2016, opening 12 new positions and adding to 64 existing holdings. Its largest new stake was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, down from 64% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Williams Companies, an estimated $4.42M trimmed.

  • Virtus ETF Advisers's largest Q3 2016 buy was iShares Expanded Tech Sector ETF: 131,364 shares worth $2.71M.
  • Virtus ETF Advisers added most to Energy Transfer Partners L.p. in Q3 2016, an estimated $6.79M increase.
  • Virtus ETF Advisers's biggest Q3 2016 reduction was Williams Companies, cutting an estimated $4.42M.
  • Virtus ETF Advisers fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $546K.
  • Virtus ETF Advisers's ten largest holdings make up 47% of its $207M portfolio in Q3 2016.
  • Virtus ETF Advisers opened 12 new positions and closed 5 in Q3 2016.
  • Virtus ETF Advisers's portfolio value rose 53% quarter-over-quarter to $207M.

Based on Virtus ETF Advisers's 13F filing for Q3 2016, filed 14 Nov 2016.